PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 5, 2026Journal of the American College of Cardiology391 citations

Impact of Oxypurinol in Patients With Symptomatic Heart Failure

View Full Paper
JHJoshua M. HareBMBrian MangalJBJoanne Brown

Key Points

Key points are not available for this paper at this time.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Hare et al. (2008) studied this question.

synapsesocial.com/papers/69fa5ec37d441863e5502420https://doi.org/10.1016/j.jacc.2008.01.068
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Xanthine oxidase inhibition ameliorates cardiovascular dysfunction in dogs with pacing-induced heart failure2005 · 71 citations
  2. 2Rationale, design and organisation of an efficacy and safety study of oxypurinol added to standard therapy in patients with NYHA class III – IV congestive heart failure2004 · 58 citations
  3. 3Uric Acid, Hominoid Evolution, and the Pathogenesis of Salt-Sensitivity2002 · 564 citations
  4. 4Electron Spin Resonance Characterization of Vascular Xanthine and NAD(P)H Oxidase Activity in Patients With Coronary Artery Disease2003 · 295 citations
  5. 5Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure2001 · 398 citations